This report focuses on the global Respiratory Distress Syndrome status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Respiratory Distress Syndrome development in Europe, China, Iran, United States and Korea.
The key players covered in this study
Chiesi Farmaceutici
CR-Double Crane
ONY Biotech
AbbVie
Yuhan Corporation
JW Pharmaceuticals
Noargen
Market Breakdown by Regions
North America
Europe
China
Korea
RoW
Market segment by Type, the product can be split into
Poractant Alfa
Beractant
Calfactant
Others
Poractant Alpha's largest market share is broken down to 67%.
Market segment by Application, split into
Very Preterm Infants
Moderate to Late Preterm Infants
Others
Very Preterm shapes the largest segment of the application market
Market segment by Regions/Countries, this report covers
Europe
China
Iran
United States
Korea
The study objectives of this report are:
To analyze global Respiratory Distress Syndrome status, future forecast, growth opportunity, key market and key players.
To present the Respiratory Distress Syndrome development in Europe, China, Iran, United States and Korea.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Respiratory Distress Syndrome are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
The key players covered in this study
Chiesi Farmaceutici
CR-Double Crane
ONY Biotech
AbbVie
Yuhan Corporation
JW Pharmaceuticals
Noargen
Market Breakdown by Regions
North America
Europe
China
Korea
RoW
Market segment by Type, the product can be split into
Poractant Alfa
Beractant
Calfactant
Others
Poractant Alpha's largest market share is broken down to 67%.
Market segment by Application, split into
Very Preterm Infants
Moderate to Late Preterm Infants
Others
Very Preterm shapes the largest segment of the application market
Market segment by Regions/Countries, this report covers
Europe
China
Iran
United States
Korea
The study objectives of this report are:
To analyze global Respiratory Distress Syndrome status, future forecast, growth opportunity, key market and key players.
To present the Respiratory Distress Syndrome development in Europe, China, Iran, United States and Korea.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Respiratory Distress Syndrome are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Respiratory Distress Syndrome Market Size Growth Rate by Type (2014-2025)
1.4.2 Poractant Alfa
1.4.3 Beractant
1.4.4 Calfactant
1.4.5 Others
1.5 Market by Application
1.5.1 Global Respiratory Distress Syndrome Market Share by Application (2019-2025)
1.5.2 Very Preterm Infants
1.5.3 Moderate to Late Preterm Infants
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Respiratory Distress Syndrome Market Size
2.2 Respiratory Distress Syndrome Growth Trends by Regions
2.2.1 Respiratory Distress Syndrome Market Size by Regions (2019-2025)
2.2.2 Respiratory Distress Syndrome Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Respiratory Distress Syndrome Market Size by by Players
3.1.1 Global Respiratory Distress Syndrome Revenue by by Players (2014-2019)
3.1.2 Global Respiratory Distress Syndrome Revenue Market Share by by Players (2014-2019)
3.1.3 Global Respiratory Distress Syndrome Market Concentration Ratio (CR5 and HHI)
3.2 Respiratory Distress Syndrome Key Players Head office and Area Served
3.3 Key Players Respiratory Distress Syndrome Product/Solution/Service
3.4 Date of Enter into Respiratory Distress Syndrome Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Respiratory Distress Syndrome Market Size by Type (2014-2019)
4.2 Global Respiratory Distress Syndrome Market Size by Application (2014-2019)
5 Europe
5.1 Europe Respiratory Distress Syndrome Market Size (2014-2019)
5.2 Respiratory Distress Syndrome Key Players in Europe
5.3 Europe Respiratory Distress Syndrome Market Size by Type
5.4 Europe Respiratory Distress Syndrome Market Size by Application
6 China
6.1 China Respiratory Distress Syndrome Market Size (2014-2019)
6.2 Respiratory Distress Syndrome Key Players in China
6.3 China Respiratory Distress Syndrome Market Size by Type
6.4 China Respiratory Distress Syndrome Market Size by Application
7 Iran
7.1 Iran Respiratory Distress Syndrome Market Size (2014-2019)
7.2 Respiratory Distress Syndrome Key Players in Iran
7.3 Iran Respiratory Distress Syndrome Market Size by Type
7.4 Iran Respiratory Distress Syndrome Market Size by Application
8 United States
8.1 United States Respiratory Distress Syndrome Market Size (2014-2019)
8.2 Respiratory Distress Syndrome Key Players in United States
8.3 United States Respiratory Distress Syndrome Market Size by Type
8.4 United States Respiratory Distress Syndrome Market Size by Application
9 Korea
9.1 Korea Respiratory Distress Syndrome Market Size (2014-2019)
9.2 Respiratory Distress Syndrome Key Players in Korea
9.3 Korea Respiratory Distress Syndrome Market Size by Type
9.4 Korea Respiratory Distress Syndrome Market Size by Application
10 International Players Profiles
10.1 Chiesi Farmaceutici
10.1.1 Chiesi Farmaceutici Company Details
10.1.2 Company Description and Business Overview
10.1.3 Respiratory Distress Syndrome Introduction
10.1.4 Chiesi Farmaceutici Revenue in Respiratory Distress Syndrome Business (2014-2019))
10.1.5 Chiesi Farmaceutici Recent Development
10.2 CR-Double Crane
10.2.1 CR-Double Crane Company Details
10.2.2 Company Description and Business Overview
10.2.3 Respiratory Distress Syndrome Introduction
10.2.4 CR-Double Crane Revenue in Respiratory Distress Syndrome Business (2014-2019)
10.2.5 CR-Double Crane Recent Development
10.3 ONY Biotech
10.3.1 ONY Biotech Company Details
10.3.2 Company Description and Business Overview
10.3.3 Respiratory Distress Syndrome Introduction
10.3.4 ONY Biotech Revenue in Respiratory Distress Syndrome Business (2014-2019)
10.3.5 ONY Biotech Recent Development
10.4 AbbVie
10.4.1 AbbVie Company Details
10.4.2 Company Description and Business Overview
10.4.3 Respiratory Distress Syndrome Introduction
10.4.4 AbbVie Revenue in Respiratory Distress Syndrome Business (2014-2019)
10.4.5 AbbVie Recent Development
10.5 Yuhan Corporation
10.5.1 Yuhan Corporation Company Details
10.5.2 Company Description and Business Overview
10.5.3 Respiratory Distress Syndrome Introduction
10.5.4 Yuhan Corporation Revenue in Respiratory Distress Syndrome Business (2014-2019)
10.5.5 Yuhan Corporation Recent Development
10.6 JW Pharmaceuticals
10.6.1 JW Pharmaceuticals Company Details
10.6.2 Company Description and Business Overview
10.6.3 Respiratory Distress Syndrome Introduction
10.6.4 JW Pharmaceuticals Revenue in Respiratory Distress Syndrome Business (2014-2019)
10.6.5 JW Pharmaceuticals Recent Development
10.7 Noargen
10.7.1 Noargen Company Details
10.7.2 Company Description and Business Overview
10.7.3 Respiratory Distress Syndrome Introduction
10.7.4 Noargen Revenue in Respiratory Distress Syndrome Business (2014-2019)
10.7.5 Noargen Recent Development
10.8 Market Breakdown by Regions
10.8.1 Market Breakdown by Regions Company Details
10.8.2 Company Description and Business Overview
10.8.3 Respiratory Distress Syndrome Introduction
10.8.4 Market Breakdown by Regions Revenue in Respiratory Distress Syndrome Business (2014-2019)
10.8.5 Market Breakdown by Regions Recent Development
10.9 North America
10.9.1 North America Company Details
10.9.2 Company Description and Business Overview
10.9.3 Respiratory Distress Syndrome Introduction
10.9.4 North America Revenue in Respiratory Distress Syndrome Business (2014-2019)
10.9.5 North America Recent Development
10.10 Europe
10.10.1 Europe Company Details
10.10.2 Company Description and Business Overview
10.10.3 Respiratory Distress Syndrome Introduction
10.10.4 Europe Revenue in Respiratory Distress Syndrome Business (2014-2019)
10.10.5 Europe Recent Development
10.11 China
10.12 Korea
10.13 RoW
11 Market Forecast 2019-2025
11.1 Market Size Forecast by Product (2019-2025)
11.2 Market Size Forecast by Application (2019-2025)
11.3 Market Size Forecast by Regions
11.4 Europe
11.5 China
11.6 Iran
11.7 United States
11.8 Korea
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Disclaimer
13.3 Author Details
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Respiratory Distress Syndrome Market Size Growth Rate by Type (2014-2025)
1.4.2 Poractant Alfa
1.4.3 Beractant
1.4.4 Calfactant
1.4.5 Others
1.5 Market by Application
1.5.1 Global Respiratory Distress Syndrome Market Share by Application (2019-2025)
1.5.2 Very Preterm Infants
1.5.3 Moderate to Late Preterm Infants
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Respiratory Distress Syndrome Market Size
2.2 Respiratory Distress Syndrome Growth Trends by Regions
2.2.1 Respiratory Distress Syndrome Market Size by Regions (2019-2025)
2.2.2 Respiratory Distress Syndrome Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Respiratory Distress Syndrome Market Size by by Players
3.1.1 Global Respiratory Distress Syndrome Revenue by by Players (2014-2019)
3.1.2 Global Respiratory Distress Syndrome Revenue Market Share by by Players (2014-2019)
3.1.3 Global Respiratory Distress Syndrome Market Concentration Ratio (CR5 and HHI)
3.2 Respiratory Distress Syndrome Key Players Head office and Area Served
3.3 Key Players Respiratory Distress Syndrome Product/Solution/Service
3.4 Date of Enter into Respiratory Distress Syndrome Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Respiratory Distress Syndrome Market Size by Type (2014-2019)
4.2 Global Respiratory Distress Syndrome Market Size by Application (2014-2019)
5 Europe
5.1 Europe Respiratory Distress Syndrome Market Size (2014-2019)
5.2 Respiratory Distress Syndrome Key Players in Europe
5.3 Europe Respiratory Distress Syndrome Market Size by Type
5.4 Europe Respiratory Distress Syndrome Market Size by Application
6 China
6.1 China Respiratory Distress Syndrome Market Size (2014-2019)
6.2 Respiratory Distress Syndrome Key Players in China
6.3 China Respiratory Distress Syndrome Market Size by Type
6.4 China Respiratory Distress Syndrome Market Size by Application
7 Iran
7.1 Iran Respiratory Distress Syndrome Market Size (2014-2019)
7.2 Respiratory Distress Syndrome Key Players in Iran
7.3 Iran Respiratory Distress Syndrome Market Size by Type
7.4 Iran Respiratory Distress Syndrome Market Size by Application
8 United States
8.1 United States Respiratory Distress Syndrome Market Size (2014-2019)
8.2 Respiratory Distress Syndrome Key Players in United States
8.3 United States Respiratory Distress Syndrome Market Size by Type
8.4 United States Respiratory Distress Syndrome Market Size by Application
9 Korea
9.1 Korea Respiratory Distress Syndrome Market Size (2014-2019)
9.2 Respiratory Distress Syndrome Key Players in Korea
9.3 Korea Respiratory Distress Syndrome Market Size by Type
9.4 Korea Respiratory Distress Syndrome Market Size by Application
10 International Players Profiles
10.1 Chiesi Farmaceutici
10.1.1 Chiesi Farmaceutici Company Details
10.1.2 Company Description and Business Overview
10.1.3 Respiratory Distress Syndrome Introduction
10.1.4 Chiesi Farmaceutici Revenue in Respiratory Distress Syndrome Business (2014-2019))
10.1.5 Chiesi Farmaceutici Recent Development
10.2 CR-Double Crane
10.2.1 CR-Double Crane Company Details
10.2.2 Company Description and Business Overview
10.2.3 Respiratory Distress Syndrome Introduction
10.2.4 CR-Double Crane Revenue in Respiratory Distress Syndrome Business (2014-2019)
10.2.5 CR-Double Crane Recent Development
10.3 ONY Biotech
10.3.1 ONY Biotech Company Details
10.3.2 Company Description and Business Overview
10.3.3 Respiratory Distress Syndrome Introduction
10.3.4 ONY Biotech Revenue in Respiratory Distress Syndrome Business (2014-2019)
10.3.5 ONY Biotech Recent Development
10.4 AbbVie
10.4.1 AbbVie Company Details
10.4.2 Company Description and Business Overview
10.4.3 Respiratory Distress Syndrome Introduction
10.4.4 AbbVie Revenue in Respiratory Distress Syndrome Business (2014-2019)
10.4.5 AbbVie Recent Development
10.5 Yuhan Corporation
10.5.1 Yuhan Corporation Company Details
10.5.2 Company Description and Business Overview
10.5.3 Respiratory Distress Syndrome Introduction
10.5.4 Yuhan Corporation Revenue in Respiratory Distress Syndrome Business (2014-2019)
10.5.5 Yuhan Corporation Recent Development
10.6 JW Pharmaceuticals
10.6.1 JW Pharmaceuticals Company Details
10.6.2 Company Description and Business Overview
10.6.3 Respiratory Distress Syndrome Introduction
10.6.4 JW Pharmaceuticals Revenue in Respiratory Distress Syndrome Business (2014-2019)
10.6.5 JW Pharmaceuticals Recent Development
10.7 Noargen
10.7.1 Noargen Company Details
10.7.2 Company Description and Business Overview
10.7.3 Respiratory Distress Syndrome Introduction
10.7.4 Noargen Revenue in Respiratory Distress Syndrome Business (2014-2019)
10.7.5 Noargen Recent Development
10.8 Market Breakdown by Regions
10.8.1 Market Breakdown by Regions Company Details
10.8.2 Company Description and Business Overview
10.8.3 Respiratory Distress Syndrome Introduction
10.8.4 Market Breakdown by Regions Revenue in Respiratory Distress Syndrome Business (2014-2019)
10.8.5 Market Breakdown by Regions Recent Development
10.9 North America
10.9.1 North America Company Details
10.9.2 Company Description and Business Overview
10.9.3 Respiratory Distress Syndrome Introduction
10.9.4 North America Revenue in Respiratory Distress Syndrome Business (2014-2019)
10.9.5 North America Recent Development
10.10 Europe
10.10.1 Europe Company Details
10.10.2 Company Description and Business Overview
10.10.3 Respiratory Distress Syndrome Introduction
10.10.4 Europe Revenue in Respiratory Distress Syndrome Business (2014-2019)
10.10.5 Europe Recent Development
10.11 China
10.12 Korea
10.13 RoW
11 Market Forecast 2019-2025
11.1 Market Size Forecast by Product (2019-2025)
11.2 Market Size Forecast by Application (2019-2025)
11.3 Market Size Forecast by Regions
11.4 Europe
11.5 China
11.6 Iran
11.7 United States
11.8 Korea
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Disclaimer
13.3 Author Details
